234 related articles for article (PubMed ID: 9223674)
1. The familial Wilms' tumour susceptibility gene, FWT1, may not be a tumour suppressor gene.
Rahman N; Arbour L; Tonin P; Baruchel S; Pritchard-Jones K; Narod SA; Stratton MR
Oncogene; 1997 Jun; 14(25):3099-102. PubMed ID: 9223674
[TBL] [Abstract][Full Text] [Related]
2. Evidence for a familial Wilms' tumour gene (FWT1) on chromosome 17q12-q21.
Rahman N; Arbour L; Tonin P; Renshaw J; Pelletier J; Baruchel S; Pritchard-Jones K; Stratton MR; Narod SA
Nat Genet; 1996 Aug; 13(4):461-3. PubMed ID: 8696342
[TBL] [Abstract][Full Text] [Related]
3. Familial predisposition to Wilms' tumour does not map to the short arm of chromosome 11.
Grundy P; Koufos A; Morgan K; Li FP; Meadows AT; Cavenee WK
Nature; 1988 Nov; 336(6197):374-6. PubMed ID: 2848199
[TBL] [Abstract][Full Text] [Related]
4. Evidence for susceptibility genes to familial Wilms tumour in addition to WT1, FWT1 and FWT2.
Rapley EA; Barfoot R; Bonaïti-Pellié C; Chompret A; Foulkes W; Perusinghe N; Reeve A; Royer-Pokora B; Schumacher V; Shelling A; Skeen J; de Tourreil S; Weirich A; Pritchard-Jones K; Stratton MR; Rahman N
Br J Cancer; 2000 Jul; 83(2):177-83. PubMed ID: 10901367
[TBL] [Abstract][Full Text] [Related]
5. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
[TBL] [Abstract][Full Text] [Related]
6. Confirmation of FWT1 as a Wilms' tumour susceptibility gene and phenotypic characteristics of Wilms' tumour attributable to FWT1.
Rahman N; Abidi F; Ford D; Arbour L; Rapley E; Tonin P; Barton D; Batcup G; Berry J; Cotter F; Davison V; Gerrard M; Gray E; Grundy R; Hanafy M; King D; Lewis I; Ridolfi Luethy A; Madlensky L; Mann J; O'Meara A; Oakhill T; Skolnick M; Strong L; Stratton MR
Hum Genet; 1998 Nov; 103(5):547-56. PubMed ID: 9860296
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations.
Baird P; Wadey R; Cowell J
Oncogene; 1991 Jul; 6(7):1147-9. PubMed ID: 1861864
[TBL] [Abstract][Full Text] [Related]
8. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
Pritchard-Jones K; Fleming S
Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of E-cadherin and cadherin-11 in Wilms' tumours.
Schulz S; Becker KF; Braungart E; Reichmuth C; Klamt B; Becker I; Atkinson M; Gessler M; Höfler H
J Pathol; 2000 Jun; 191(2):162-9. PubMed ID: 10861576
[TBL] [Abstract][Full Text] [Related]
10. Nonlinkage of 16q markers to familial predisposition to Wilms' tumor.
Huff V; Reeve AE; Leppert M; Strong LC; Douglass EC; Geiser CF; Li FP; Meadows A; Callen DF; Lenoir G
Cancer Res; 1992 Nov; 52(21):6117-20. PubMed ID: 1356625
[TBL] [Abstract][Full Text] [Related]
11. Genetic mosaicism in normal tissues of Wilms' tumour patients.
Chao LY; Huff V; Tomlinson G; Riccardi VM; Strong LC; Saunders GF
Nat Genet; 1993 Feb; 3(2):127-31. PubMed ID: 8388768
[TBL] [Abstract][Full Text] [Related]
12. Preferential loss of maternal alleles in sporadic Wilms' tumour.
Pal N; Wadey RB; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Nov; 5(11):1665-8. PubMed ID: 1980007
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity at 7p in Wilms' tumour development.
Powlesland RM; Charles AK; Malik KT; Reynolds PA; Pires S; Boavida M; Brown KW
Br J Cancer; 2000 Jan; 82(2):323-9. PubMed ID: 10646884
[TBL] [Abstract][Full Text] [Related]
14. Molecular and cellular biology of Wilms' tumour.
Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
[TBL] [Abstract][Full Text] [Related]
15. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
[TBL] [Abstract][Full Text] [Related]
16. Role of the WT1 gene in Wilms' tumour.
Haber DA; Housman DE
Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
[TBL] [Abstract][Full Text] [Related]
17. Familial Wilms tumor.
Ruteshouser EC; Huff V
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):29-34. PubMed ID: 15264270
[TBL] [Abstract][Full Text] [Related]
18. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11.
Wadey RB; Pal N; Buckle B; Yeomans E; Pritchard J; Cowell JK
Oncogene; 1990 Jun; 5(6):901-7. PubMed ID: 2163053
[TBL] [Abstract][Full Text] [Related]
19. Lack of linkage of familial Wilms' tumour to chromosomal band 11p13.
Huff V; Compton DA; Chao LY; Strong LC; Geiser CF; Saunders GF
Nature; 1988 Nov; 336(6197):377-8. PubMed ID: 2848200
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel regions of deletion in familial Wilms' tumor by comparative genomic hybridization.
Altura RA; Valentine M; Li H; Boyett JM; Shearer P; Grundy P; Shapiro DN; Look AT
Cancer Res; 1996 Aug; 56(16):3837-41. PubMed ID: 8706032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
